Pre-eclampsia onset and SPARC: A possible involvement in placenta development

Area of Science:

• Obstetrics and Gynecology
• Reproductive Biology
• Cellular and Molecular Medicine

Background:

• Pre-eclampsia (PE) is a serious pregnancy complication affecting multiple systems, often leading to intrauterine fetal growth retardation (IUGR).
• The role of specific proteins, such as SPARC (secreted protein acidic and rich in cysteine), in the pathophysiology of PE and PE-IUGR is not fully understood.

Purpose of the Study:

• To investigate the localization and expression patterns of SPARC in placentas from normal pregnancies, PE, and PE-IUGR.
• To explore the potential role of SPARC in the development of PE and PE-IUGR.

Main Methods:

• Immunohistochemical analysis of SPARC expression in placental tissues from different pregnancy conditions (normal, PE, PE-IUGR) across trimesters.
• In vitro studies using cell models to investigate the influence of hypoxic conditions on SPARC expression.

Main Results:

• SPARC expression was observed in villous and extravillous cytotrophoblastic cells in the first trimester.
• In PE, PE-IUGR, and term placentas, SPARC was found in both cytotrophoblastic cells and the syncytiotrophoblast.
• SPARC expression significantly decreased from the first to the third trimester in normal placentas, with a further significant reduction in PE and PE-IUGR placentas.
• Downregulation of SPARC in PE and PE-IUGR was found to be dependent on hypoxic conditions.

Conclusions:

• SPARC expression is significantly altered in pre-eclampsia and PE-IUGR placentas.
• The downregulation of SPARC appears to be influenced by hypoxia.
• SPARC may play a critical role in the pathogenesis of pre-eclampsia and intrauterine fetal growth retardation, warranting further investigation.